QIAGEN (QGENF) - Star of Germany's Biotechs Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QIAGEN (QGENF) - Star of Germany's Biotechs

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Zeitgeist who wrote (6)	1/10/1997 8:31:00 PM
From: (no name provided)	of 122

Stefan, I find your English excellent, better than most native speakers. However, QGENF is not so excellent. Montgomery just (1/10/97) decreased their EPS estimates for the fourth quarter 1996 ($0.11 down from $0.13). They did maintain future estimates and a buy rating. The restricted stock is no longer restricted so the venture capitalists are free to sell. Be very careful with this one, it is bound to fall eventually. Yes, I am short and would be short more if I could borrow it. Kafka666

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next